Botulinum toxin A - Lipella Pharmaceuticals

Drug Profile

Botulinum toxin A - Lipella Pharmaceuticals

Alternative Names: Lipo-BoNT; Liposomal botulinum toxin A - Lipella Pharmaceuticals; Liposome encapsulated BoNT-A - Lipella; Lipotoxin - Lipella; LP-09; OnabotulinumtoxinA - Lipella

Latest Information Update: 23 Mar 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Lipella Pharmaceuticals
  • Developer Buddhist Tzu Chi General Hospital; Lipella Pharmaceuticals
  • Class Antispasmodics; Bacterial proteins; Bacterial toxins; Botulinum toxins; Muscle relaxants
  • Mechanism of Action Acetylcholine inhibitors; Glutamate-antagonists; Neuromuscular blocking agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Interstitial cystitis; Overactive bladder

Most Recent Events

  • 23 Mar 2017 Phase-II development for Overactive bladder is ongoing in Taiwan
  • 23 Mar 2017 Lipella's botulinum toxin-A licensed to an unknown company worldwide (Lipella Pharmaceuticals website, March 2017)
  • 01 Feb 2017 Buddhist Tzu Chi General Hospital completes a phase II trial in Interstitial cystitis (In adults, In the elderly) in Taiwan (Intravesicular) (NCT02247557)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top